BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28578901)

  • 1. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
    Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
    Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
    Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
    JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
    Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
    JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.
    Taipale H; Mehtälä J; Tanskanen A; Tiihonen J
    Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study.
    Taipale H; Tanskanen A; Correll CU; Tiihonen J
    Lancet Psychiatry; 2022 Apr; 9(4):271-279. PubMed ID: 35182475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
    Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
    Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
    Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
    Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.
    Baethge C; Gruschka P; Smolka MN; Berghöfer A; Bschor T; Müller-Oerlinghausen B; Bauer M
    J Psychiatry Neurosci; 2003 Sep; 28(5):355-61. PubMed ID: 14517579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study.
    Lähteenvuo M; Paljärvi T; Tanskanen A; Taipale H; Tiihonen J
    Br J Psychiatry; 2023 Oct; 223(4):456-464. PubMed ID: 37395140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs.
    Matza LS; Rajagopalan KS; Thompson CL; de Lissovoy G
    J Clin Psychiatry; 2005 Nov; 66(11):1432-40. PubMed ID: 16420081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
    Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
    J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics in the maintenance phase for psychotic depression.
    Al-Wandi A; Landén M; Nordenskjöld A
    Acta Psychiatr Scand; 2024 Jan; 149(1):6-17. PubMed ID: 37932158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
    Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
    BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study.
    Greil W; Ludwig-Mayerhofer W; Erazo N; Engel RR; Czernik A; Giedke H; Müller-Oerlinghausen B; Osterheider M; Rudolf GA; Sauer H; Tegeler J; Wetterling T
    J Affect Disord; 1996 Oct; 40(3):179-90. PubMed ID: 8897118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
    Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
    Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.